Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05189080 · ClinicalTrials.gov registry record · NA
Twilio Well-Child Visit Pilot Open Trial
A NA study of Child Health and Text Messaging, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05189080 is a NA study of Child Health and Text Messaging that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05189080, a NA study of Child Health and Text Messaging, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will use Twilio as a platform for a text messaging campaign to implement timely follow up with parents/guardians of children ages 0 to 17 years who have no-showed for WCVs. The first phase of the study will be an open trial to assess feasibility and acceptability of three different reminder messages, analyze preliminary data, and collect feedback from participants using interviews to identify the top one or two performing messages. Each reminder message will at minimum direct parents/guardians to reschedule by phone or by the patient portal. These findings will be used to conduct the second phase of the study, a randomized controlled trial.
Conditions Studied
Interventions
- OTHER Survey
- OTHER Interviews
- OTHER Text message reminders
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2022-04-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05189080
The ClinicalTrials.gov registry entry for NCT05189080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Child Health appearing as the primary indexed condition, and to 3 interventions - of which Survey is the first listed.
NCT05189080 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05189080 about?
NCT05189080 is a clinical study titled "Twilio Well-Child Visit Pilot Open Trial". This project will use Twilio as a platform for a text messaging campaign to implement timely follow up with parents/guardians of children ages 0 to 17 years who have no-showed for WCVs. The first phase of the study will be an open trial to assess feasibility and acceptability of three different remi...
What is the current status of trial NCT05189080?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2021-12-17. Estimated completion is 2022-04-08.
What conditions does trial NCT05189080 study?
This clinical trial studies the following conditions: Child Health, Text Messaging.
What interventions are being tested in trial NCT05189080?
The interventions under investigation include: Survey (OTHER), Interviews (OTHER), Text message reminders (OTHER).
Who is sponsoring clinical trial NCT05189080?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05189080 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.